Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.
The therapeutic efficacy of an experimental antiviral agent, WIN 54954, was evaluated in murine myocardial infection with coxsackievirus A9 (CVA9). Eight-month-old male Swiss Webster mice were inoculated with 1.5 x 10(4) PFU of CVA9, Boston strain 13. WIN 54954, a broad-spectrum antipicornavirus age...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1992
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1318683/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.2.425 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|